CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The RESTAVAC project focuses on understanding the regulatory mechanisms of Staphylococcus aureus, a common skin bacterium that can cause serious infections. By analyzing the expression of potential vaccine antigens, the project aims to inform vaccine development and enhance knowledge of bacterial pathogenesis.
Staphylococcus aureus is a commensal of the human skin and nares, and a major cause of skin, and soft tissue as well as invasive infections.
Bacterial pathogenicity results from a complex interplay of virulence factors with regulatory systems that respond to multiple external signals from the host environment and the bacterial population.
Currently no vaccine against S. aureus is available.
Novartis Vaccines and Diagnostics (NVD) has employed the reverse vaccinology approach to identify a list o…
GLAXOSMITHKLINE VACCINES SRL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
